Navigation Links
New IDSAF and NIA Research Grants will Speed Alzheimer’s Microbe Hunt, Says Dr. Leslie Norins of Alzheimer’s Germ Quest, Inc.
Date:6/20/2019

The half-million dollars in Alzheimer’s disease (AD) research grants recently announced by the Infectious Diseases Society of America Foundation, and the possibly millions of dollars of “high priority” grants now offered by the National Institute on Aging to study infectious agents in AD, are a “welcome affirmation” of the need to investigate more thoroughly the possible roles of germs in triggering AD, says Leslie Norins, MD, PhD, CEO of Alzheimer’s Germ Quest, Inc.

“This new funding from these two authorities will help alleviate a severe shortage of research grants to follow up many promising leads that viruses, bacteria and other pathogens are involved in AD,” says Dr. Norins. He urges scientists with microbiological talents to apply.

Strangely, he says, several AD advocacy groups appear to still be ignoring microbes, and continue to channel their research grant monies almost exclusively to the traditional topics of amyloid plaques and tau tangles. Dr. Norins attributes this to a lack of infectious diseases experts on their policy and grant review committees.

Dr. Norins also points to a recent article in ALZFORUM, which reported that an anti-viral medication administered to fight hepatitis C might also reduce the later development of Parkinson’s disease. It said, “[This] supports emerging evidence that infections contribute to neurodegeneration.” Dr. Norins reminds, “AD, like Parkinson’s, is a leading neurodegenerative disease.”

Alzheimer’s Germ Quest is a public benefit corporation, headquartered in Naples. Florida. It is self-funded, and neither solicits nor accepts outside donations. Its mission is to accelerate and deepen research into the possibility that a microbiological agent triggers AD. It is the sponsor of the $1 million Challenge Award for the scientist who proves an infectious organism is the cause of AD. Recently, it launched a $100,000 hunt for the world’s first provable case of spontaneous cure of AD.

Read the full story at https://www.prweb.com/releases/new_idsaf_and_nia_research_grants_will_speed_alzheimers_microbe_hunt_says_dr_leslie_norins_of_alzheimers_germ_quest_inc/prweb16390545.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Trivedi Global, Inc. Announces Research by Dahryn Trivedi on the Beneficial Impact of Energy Treated Cefazolin Sodium Antibiotic in Treating Bacterial Infections
2. Research from Ambry Genetics & Mayo Clinic Reveals Differences in the Prevalence of Breast Cancer Genes among Racial and Ethnic Populations
3. Ambry Genetics Research Demonstrates RNA Genetic Testing in Hereditary Cancer Improves Variant Classification and Patient Management
4. ASGCT To Honor Four Ground-Breaking Researchers at 22nd Annual Meeting
5. ACEA Presents xCELLigence Research Grant to Dr. Teresa Krabbe
6. VCU College of Engineering and Fuzionaire Diagnostics to Pursue Joint Research Applying Novel Radiochemistry Platform to Disease Diagnosis and Drug Discovery
7. uBiome Appoints Dr. Julia Oh, PhD, Skin Microbiome Researcher, to its Scientific Advisory Board
8. uBiome Launches Research Collaboration with doc.ai to Potentially Predict Optimal Supplements for Crohn’s Disease
9. Mount Sinai Researchers Use “Blacklist” Computing Concept as Novel Method to Streamline Genetic Analysis
10. Biocompare Releases Documentary on “What Researchers Need to Know about Antibody Manufacturing”
11. ACEA Biosciences Joins Cell Manufacturing Research Initiative to Further Advance Cell Therapy Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, has ... own adipose-derived stem cells to treat their osteoarthritis. The first clinical trial, expected to ... , This is the first of several planned clinical trials which will ...
(Date:7/21/2019)... ... July 20, 2019 , ... ... ( http://www.fluidimaging.com ) announced today the release of the biggest software update ... and characterization platform will provide a significant increase in productivity for its ...
(Date:7/19/2019)... (PRWEB) , ... July 19, 2019 , ... ... Solids between Amorphous and Crystalline States – Insights from Synchrotron X-ray Pair Distribution ... Improved Pharma, along with Chris Benmore of Argonne National Laboratory and Gabriel de ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... June 11, 2019 , ... Veterinary Regenerative Medicine company, ... has announced that their GMP facility for cell production is now approved by ... This is an important milestone for VetStem as it expands into contract cell ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... providing proprietary interest to our methodology, processes, and diagnostic techniques. The patent ... extends Somnology’s IP rights including our proprietary sleep scoring methodology. The approval ...
(Date:5/22/2019)... ... , ... Artemis (formerly Agrilyst), the leading enterprise Cultivation Management Platform ... by Astanor Ventures and Talis Capital with participation from existing ... . The company has raised $11.75m to date and will use the new funding ...
(Date:5/14/2019)... (PRWEB) , ... May 13, 2019 , ... ... built, helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food ... company website. The redesigned website aims to improve LDA’s ability to communicate directly ...
Breaking Biology Technology: